0001104659-24-027724.txt : 20240226
0001104659-24-027724.hdr.sgml : 20240226
20240226200632
ACCESSION NUMBER: 0001104659-24-027724
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240222
FILED AS OF DATE: 20240226
DATE AS OF CHANGE: 20240226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nayak Sanjay
CENTRAL INDEX KEY: 0002012715
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36554
FILM NUMBER: 24681395
MAIL ADDRESS:
STREET 1: C/O OCULAR THERAPEUTIX, INC.
STREET 2: 24 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OCULAR THERAPEUTIX, INC
CENTRAL INDEX KEY: 0001393434
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 24 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: 781-895-3235
MAIL ADDRESS:
STREET 1: 24 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
FORMER COMPANY:
FORMER CONFORMED NAME: I-THERAPEUTIX INC
DATE OF NAME CHANGE: 20070315
4
1
tm247229-3_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-22
0
0001393434
OCULAR THERAPEUTIX, INC
OCUL
0002012715
Nayak Sanjay
C/O OCULAR THERAPEUTIX, INC.
24 CROSBY DRIVE
BEDFORD
MA
01730
0
1
0
0
Chief Strategy Officer
0
Common Stock
2024-02-22
4
A
0
80300
0
A
180300
D
Stock Option (Right to Buy)
9.70
2024-02-22
4
A
0
244550
0
A
2024-02-21
Common Stock
244550
244550
D
On February 22, 2024, the reporting person was granted restricted stock units ("RSUs") under the 2019 Inducement Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, in equal quarterly installments, beginning on the date of grant.
Vests over four years, with 1/4 of the shares underlying the option vesting on the one-year anniversary of the date the reporting person commenced employment with the Corporation and 1/48 of the shares underlying the option vesting monthly thereafter.
/s/ Donald Notman, Attorney-in-Fact for Sanjay Nayak
2024-02-26